Literature DB >> 30838988

Spontaneous pneumomediastinum (Hamman's syndrome): presenting as acute severe asthma.

Waddah Mohamed1, Claire Exley1, Ian Michael Sutcliffe1, Akshay Dwarakanath2.   

Abstract

Spontaneous pneumomediastinum (SPM) is an uncommon finding and clinicians must consider this during their clinical evaluation. High degree of suspicion and appropriate investigations play key roles in early diagnosis and avoiding potential life-threatening complications. SPM usually presents without any comorbidities (primary) or due to an underlying pathology (secondary), such as underlying asthma, barotrauma, valsalva manoeuvre or an oesophageal rupture. Patients can have varying clinical symptoms; the majority will have subcutaneous emphysema and Hamman's sign (mediastinal crunching sound on auscultation). The prognosis of SPM is usually good with resolution in most cases, and it has a low recurrence rate. We report a case of SPM in a young 19-year-old male who presented with symptoms of acute severe asthma and who made a complete resolution with conservative management.

Entities:  

Keywords:  CT chest; Hamman’s sign; pneumomediastinum; subcutaneous emphysema

Mesh:

Year:  2019        PMID: 30838988     DOI: 10.4997/JRCPE.2019.106

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  3 in total

1.  Spontaneous pneumomediastinum in diabetic ketoacidosis: A case series of 10 patients.

Authors:  Wan-Ling Xu; Li-Chao Sun; Xiu-Xian Zang; Hong Wang; Wei Li
Journal:  World J Emerg Med       Date:  2022

2.  Spontaneous Pneumomediastinum in a Young Female.

Authors:  Priyanka Modi; Prakash Ranjan Mishra; Ankit Kumar Sahu; Sanjeev Bhoi
Journal:  J Emerg Trauma Shock       Date:  2021-03-23

3.  Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease.

Authors:  Ravichandra Tata; Thrilok Chander Bingi; Akhilesh Kumar Maurya; Hemanth Kalakuntla; Saketh Gangishetti
Journal:  Cureus       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.